Certificate under Regulation 74 (5) of SEBI (DP) Regulation, 2018 for the quarter ended on 30th September, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Genomic Valley Biotech Ltd has submitted a routine compliance certificate under SEBI's Depository Regulations for the quarter ended 30 September 2025. The certificate was issued by the company's Registrar and Share Transfer Agent, Beetal Financial & Computer Services Pvt Ltd. It confirms that all physical share certificates received from Depository Participants for dematerialization during the quarter were duly verified and reported to the depositories (NSDL and CDSL). The RTA further confirms that these certificates were mutilated and cancelled, and the depositories' names were substituted as the registered owners in the company's register of members within the 15-day deadline.
This is a standard regulatory housekeeping filing with no material impact on shareholders or the stock price. It simply certifies that the company's dematerialization process is functioning in compliance with SEBI rules.